Leveraging Comparative Oncology in the Hopes of Improving Therapies for Breast Cancer

In the setting of cancer drug development, Comparative Oncology involves the inclusion of dogs with naturally occurring cancer in clinical trials of novel cancer drugs to answer questions that cannot be answered in the development of novel therapeutics using conventional animal models of cancer or human clinical trials alone [1]. The current conventional approach to oncology drug development is flawed and needs to be improved, with fewer than 3% of drugs that enter human trials advancing to human approval.
Source: Seminars in Oncology - Category: Cancer & Oncology Authors: Tags: Discussion Source Type: research